Skip to main content

Precision Medicine: A New Approach to Cancer Treatment

Thousands of cancer patients are getting medication based on the type of genes driving their disease, not the type of cancer, in a new federal study.

Republish
Lead image for this article
Credit: Linus Ekenstam

Thousands of cancer patients are getting medication based on the type of genes driving their disease, not the type of cancer, in a new federal study. The approach is a departure from past practice, in which the location of cancer tumors in the patient’s body determined medication. The National Cancer Institute will launch the precision medicine experiment at more than 2,400 locations. (Business Insider)

Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Support independent Texas news

Become a member. Join today.

Choose an amount or learn more about membership.

$20 $25 $50 Other
Donate now

Information about the authors

John Reynolds’s staff photo

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics